Literature DB >> 2752378

Cytogenetic subtype involving chromosome 13 in lipoma. Report of three cases.

C Sreekantaiah1, C S Berger, C P Karakousis, U Rao, S P Leong, A A Sandberg.   

Abstract

We report three lipomas with rearrangements of chromosome 13. The karyotype of the tumors studied were 45,XX,-8,+der(8)t(8;13)(q22;q12),del(10)(p12),-13; 46,XY,del(13)(q12q22), and 46,XY,t(11;12)(q23;q13),del(13)(q12q22), respectively, revealing common involvement of band 13q12 in the rearrangement. Three other lipomas with aberrations of bands 13q12-q13 have been reported, suggesting that such tumors with abnormalities of chromosome 13 could represent a subgroup of lipoma in addition to those already reported with abnormalities of chromosomes 12q and 6p. The rearrangements of #13 in all these cases also involved loss of the band 13q14 to which the antioncogene associated with retinoblastoma and osteosarcoma is localized. Detailed clinical, histopathologic, and molecular studies should help to further characterize the various cytogenetically defined subgroups of lipoma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2752378     DOI: 10.1016/0165-4608(89)90193-3

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  Chromosomal abnormalities in leiomyosarcomas.

Authors:  C Sreekantaiah; J R Davis; A A Sandberg
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

2.  A new cytogenetic subgroup in lipomas: loss of chromosome 16 material in spindle cell and pleomorphic lipomas.

Authors:  N Mandahl; F Mertens; H Willén; A Rydholm; O Brosjö; F Mitelman
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

3.  Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis.

Authors:  Oxana Schmidt; Nadja Nehls; Carolin Prexler; Kristina von Heyking; Tanja Groll; Katharina Pardon; Heathcliff D Garcia; Tim Hensel; Dennis Gürgen; Anton G Henssen; Angelika Eggert; Katja Steiger; Stefan Burdach; Günther H S Richter
Journal:  J Exp Clin Cancer Res       Date:  2021-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.